The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.20
Bid: 91.95
Ask: 92.25
Change: 1.45 (1.60%)
Spread: 0.30 (0.326%)
Open: 92.50
High: 93.25
Low: 91.00
Prev. Close: 90.75
HAS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

20 Jun 2022 07:30

RNS Number : 3798P
Hays PLC
20 June 2022
 

Hays plc

20 June 2022

Further to its announcement on 28 April 2022, Hays plc (the "Company") announces that it has entered into a non-discretionary arrangement with Jefferies International Limited ("Jefferies") in relation to the programme to repurchase the Company's ordinary 1 pence shares up to the value of £75million. The programme will be executed by Jefferies from the date of this announcement and will end no later than 27 March 2023. Under the programme, Jefferies will purchase shares up to the value of £62,891,553.24. As announced on 28 April 2022, the purpose of the programme is to reduce the total issued share capital of the Company.

Jefferies will purchase the Company's ordinary shares as principal and sell them on to the Company in accordance with the terms of their engagement. The Company intends to cancel the shares it purchases through the programme.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Jefferies engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's annual general meeting held on 10 November 2021 (which permits the Company to purchase no more than 167,993,631 of the Company's ordinary shares, taking into account the amount of shares already repurchased using this authority under the buyback programmes announced on 23 September 2020, 29 November 2021 and 28 April 2022), the EU Market Abuse Regulation (596/2014) as it applies in the UK, the Commission Delegated Regulation (2016/1052) as it applies in the UK and Chapter 12 of the Financial Conduct Authority's Listing Rules.

For further information please contact:

David Phillips, Head of Investor Relations and ESG on +44 (0) 333 010 7122, or ir@hays.com

LEI code: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFUFWWEESEEM
Date   Source Headline
23rd Sep 20205:25 pmRNSTransaction in Own Shares
23rd Sep 20208:00 amRNSTreasury Share Purchase Programme
18th Sep 20202:49 pmRNSDirector/PDMR Shareholding
17th Sep 20209:15 amRNSDirector/PDMR Shareholding
11th Sep 202011:45 amRNSDirector/PDMR Shareholding
9th Sep 20209:25 amRNSDirector/PDMR Shareholding
1st Sep 202010:02 amRNSDirector Declaration
1st Sep 202010:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSFinal Results
10th Aug 202012:30 pmRNSBlock listing Interim Review
5th Aug 20209:22 amRNSHolding(s) in Company
3rd Aug 202010:00 amRNSTotal Voting Rights
16th Jul 20207:00 amRNSFourth Quarter Trading Update
1st Jul 202010:00 amRNSTotal Voting Rights
1st Jun 202010:00 amRNSTotal Voting Rights
1st May 202010:00 amRNSTotal Voting Rights
9th Apr 202012:56 pmRNSHolding(s) in Company
7th Apr 20203:38 pmRNSDirector/PDMR Shareholding
3rd Apr 202010:40 amRNSDirector/PDMR Shareholding
2nd Apr 20202:34 pmRNSResults of the Placing
2nd Apr 20207:01 amRNSProposed Placing of Ordinary Shares
2nd Apr 20207:00 amRNSTrading Update & Equity Placing
1st Apr 202010:00 amRNSTotal Voting Rights
9th Mar 202010:12 amRNSDirector/PDMR Shareholding
4th Mar 20204:40 pmRNSHolding(s) in Company
2nd Mar 202010:00 amRNSTotal Voting Rights
20th Feb 20207:00 amRNSHalf-year Report
12th Feb 202012:09 pmRNSBlock listing Interim Review
3rd Feb 202010:00 amRNSTotal Voting Rights
16th Jan 20207:00 amRNSSecond Quarter Trading Update
6th Jan 20202:43 pmRNSDirector Declaration
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 20194:50 pmRNSHolding(s) in Company
2nd Dec 201910:00 amRNSTotal Voting Rights
13th Nov 20193:49 pmRNSResult of AGM
1st Nov 201910:00 amRNSTotal Voting Rights
29th Oct 20199:40 amRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSFirst Quarter Trading Update
1st Oct 20192:22 pmRNSDirector/PDMR Shareholding
1st Oct 201910:12 amRNSDirector/PDMR Shareholding
1st Oct 201910:00 amRNSTotal Voting Rights
30th Sep 20194:27 pmRNSAnnual Financial Report
13th Sep 20193:21 pmRNSDirector/PDMR Shareholding
12th Sep 201912:37 pmRNSDirector/PDMR Shareholding
9th Sep 20193:10 pmRNSDirector/PDMR Shareholding
6th Sep 201910:47 amRNSDirector/PDMR Shareholding
5th Sep 201910:00 amRNSBlock Listing Application
2nd Sep 201910:00 amRNSTotal Voting Rights
30th Aug 201910:27 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.